Business Daily.
.
The Times Real Estate
A+ R A-

Research and Markets: Skin And Soft Tissue Infections - Pipeline Review, H2 2013 Research Report

E-mail Print PDF
image image

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7768ht/skin_and_soft) has announced the addition of the "Skin And Soft Tissue Infections - Pipeline Review, H2 2013" report to their offering.

'Skin And Soft Tissue Infections - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Skin And Soft Tissue Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin And Soft Tissue Infections.

Scope

- A snapshot of the global therapeutic scenario for Skin And Soft Tissue Infections.

- A review of the Skin And Soft Tissue Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Skin And Soft Tissue Infections pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

List of Tables

List of Figures

Introduction

Skin And Soft Tissue Infections Overview

Therapeutics Development

Late Stage Products

Clinical Stage Products

Early Stage Products

Drug Profiles

dalbavancin - Drug Profile

ceftobiprole medocaril - Drug Profile

AB-103 - Drug Profile

levonadifloxacin - Drug Profile

RX-04 - Drug Profile

Gram Positive Antibiotic For SSTI And CAP - Drug Profile

Featured News & Press Releases

Appendix

Companies Mentioned

Wockhardt Limited

Basilea Pharmaceutica AG

Atox Bio Inc.

Durata Therapeutics, Inc.

Melinta Therapeutics Inc.

Demuris Ltd.

For more information visit http://www.researchandmarkets.com/research/7768ht/skin_and_soft

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Business Daily Media